Short answer
AVITA Medical, Inc. (RCEL) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $22M (up 17.8% year over year) with net income of −$8M.
Q2 2026 key financials · XBRL
- Revenue
- $22M
- +17.8% YoY · +12.7% QoQ
- Net income
- −$8M
- +22.8% YoY · +27.8% QoQ
- Operating margin
- -31.6%
- Gross margin
- 81.9%
- EPS (diluted)
- −$0.25
- +32.4% YoY · +28.6% QoQ
Source: XBRL data from the AVITA Medical, Inc. (RCEL) Q2 2026 10-Q on SEC EDGAR. USD.
AVITA Medical, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes from the 2025 Annual Report
- Carried-forward business, liquidity, operational, regulatory, and market risks remain applicable
- Potential adverse effects on financial condition, liquidity, results of operations, and capital position
- Actual results may differ materially from historical results and forward-looking statements
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other AVITA Medical, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.